Sifting through countless of stocks in the Pharmaceuticals industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Elanco Animal Health Incorporated or Indivior PLC because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Elanco Animal Health Incorporated and Indivior PLC compare based on key financial metrics to determine which better meets your investment needs.

About Elanco Animal Health Incorporated and Indivior PLC

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus, Doncit, Drontal, Drontal Plus, and Trifexis trademarks; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. The company also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, it offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, the company offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and TruCan trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. It sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Latest Pharmaceuticals and Elanco Animal Health Incorporated, Indivior PLC Stock News

As of December 2, 2025, Elanco Animal Health Incorporated had a $11.2 billion market capitalization, compared to the Pharmaceuticals median of $422.6 million. Elanco Animal Health Incorporated’s stock is NA in 2025, NA in the previous five trading days and up 71.29% in the past year.

Currently, Elanco Animal Health Incorporated’s price-earnings ratio is 316.8. Elanco Animal Health Incorporated’s trailing 12-month revenue is $4.6 billion with a 0.8% net profit margin. Year-over-year quarterly sales growth most recently was 10.4%. Analysts expect adjusted earnings to reach $0.937 per share for the current fiscal year. Elanco Animal Health Incorporated does not currently pay a dividend.

Currently, Indivior PLC’s price-earnings ratio is 34.3. Indivior PLC’s trailing 12-month revenue is $1.2 billion with a 10.5% net profit margin. Year-over-year quarterly sales growth most recently was 2.3%. Analysts expect adjusted earnings to reach $2.343 per share for the current fiscal year. Indivior PLC does not currently pay a dividend.

How We Compare Elanco Animal Health Incorporated and Indivior PLC Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Elanco Animal Health Incorporated and Indivior PLC’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Elanco Animal Health Incorporated and Indivior PLC Growth Grades

Company	Ticker	Growth
Elanco Animal Health Incorporated	ELAN	B
Indivior PLC	INDV	C

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Elanco Animal Health Incorporated has a Growth Score of 65, which is Strong. Indivior PLC has a Growth Score of 48, which is Average.

The Growth Grade Winner: Elanco Animal Health Incorporated

As you can clearly see from the Growth Grade breakdown above, Elanco Animal Health Incorporated has a more attractive growth grade than Indivior PLC. For investors who focus solely on how a company is growing relative to other companies in the same industry, Elanco Animal Health Incorporated could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Elanco Animal Health Incorporated and Indivior PLC’s Momentum Grades

Company	Ticker	Momentum
Elanco Animal Health Incorporated	ELAN	A
Indivior PLC	INDV	A

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Elanco Animal Health Incorporated has a Momentum Score of 87, which is Very Strong. Indivior PLC has a Momentum Score of 95, which is Very Strong.

The Momentum Grade Winner: It’s a Tie!

Looking at the Momentum Grade breakdown above, both Elanco Animal Health Incorporated and Indivior PLC have a grade of A. For those who focus solely on a company’s momentum, further research will need to be conducted into both companies to see if they fit your individual needs as an investor.

Elanco Animal Health Incorporated and Indivior PLC’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Elanco Animal Health Incorporated	ELAN	A
Indivior PLC	INDV	A

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Elanco Animal Health Incorporated has a Earnings Estimate Score of 81, which is Very Positive. Indivior PLC has a Earnings Estimate Score of 84, which is Very Positive.

The Earnings Estimate Revisions Grade Winner: It’s a Tie!

Looking at the Earnings Estimate Revisions Grade breakdown above, both Elanco Animal Health Incorporated and Indivior PLC have a grade of A. For those focusing solely on a company’s estimate revisions, other financial metrics will need to be evaluated to determine whether Elanco Animal Health Incorporated or Indivior PLC is a better fit.

Other Elanco Animal Health Incorporated and Indivior PLC Grades

In addition to Growth, Momentum and Estimate Revisions, A+ Investor also provides grades for Value and Quality.

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Elanco Animal Health Incorporated and Indivior PLC pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Elanco Animal Health Incorporated or Indivior PLC Stock?

Overall, Elanco Animal Health Incorporated stock has a Growth Score of 65, Momentum Score of 87 and Estimate Revisions Score of 81.

Indivior PLC stock has a Growth Score of 48, Momentum Score of 95 and Estimate Revisions Score of 84.

Comparing Elanco Animal Health Incorporated and Indivior PLC’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.